Vaccines Articles
Although more antivaccination legislation was introduced between 2011 and 2017, bills that limited vaccine exemptions were significantly more likely to be enacted.
A recent meta-analysis of pooled individual patient-level data, researchers found reduced effectiveness of the quadrivalent live-attenuated influenza vaccine (LAIV4) against influenza A/H1N1pdm09 compared with inactivated influenza vaccine (IIV) in children and adolescents.
The Human Vaccine Project aims to understand how the human immune system can develop longer-lasting protection against influenza.
FDA granted Sanofi Pasteur’s Adacel Tdap absorbed vaccine expanded indication to include repeat vaccinations for tetanus, diphtheria and pertussis.
A new survey shows more than 40 percent of Americans haven’t been vaccinated against the flu and aren’t planning to be due to misconceptions.
A new study shows pregnant women hospitalized in the ICU with flu are four times more likely to deliver prematurely and four-and-a-half times more likely to have a baby of low birth weight.
A study that examined data from more than 73,000 girls and women shows vaccines designed to prevent infection with human papillomavirus (HPV) are effective in protecting against precancerous cervical lesions in women, particularly in those vaccinated between age 15 and 26 years.
Merck’s Gardasil 9 human papillomavirus (HPV) vaccine has been approved by the U.S. Food and Drug Administration (FDA) for an expanded indication for men and women between the ages of 27 years and 45 years.
Researchers conducted a study that examined whether the childhood vaccine schedule was associated with an increased risk of infections not targeted by vaccines.
A recent meta-analysis of six studies of mumps vaccine effectiveness conducted in the U.S. found protection against mumps lasts an average of 27 years after the last dose of the vaccine.
New research shows an annual influenza (flu) shot is crucial for children with asthma.
The Centers for Disease Control and Prevention's advisory committee has voted 12-2 to recommend FluMist, the nasal spray version of the influenza vaccine, be used during the 2018-19 influenza (flu) season.
